---
title: "BMGC released its first-quarter performance, with a net profit attributable to the parent company of 166 million yuan, a year-on-year increase of 66.82%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237900356.md"
description: "According to the Zhitong Finance APP, BMGC disclosed its first-quarter report for 2025, showing that the company achieved revenue of 6.154 billion yuan during the reporting period, a year-on-year increase of 8.46%; net profit attributable to the parent company was 166 million yuan, a year-on-year increase of 66.82%; and net profit excluding non-recurring gains and losses was 164 million yuan, a year-on-year increase of 66.04%. Basic earnings per share were 0.18 yuan"
datetime: "2025-04-28T16:12:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237900356.md)
  - [en](https://longbridge.com/en/news/237900356.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237900356.md)
---

# BMGC released its first-quarter performance, with a net profit attributable to the parent company of 166 million yuan, a year-on-year increase of 66.82%

According to the Zhitong Finance APP, BMGC (600073.SH) disclosed its first-quarter report for 2025, showing that the company achieved revenue of 6.154 billion yuan during the reporting period, a year-on-year increase of 8.46%; the net profit attributable to the parent company was 166 million yuan, a year-on-year increase of 66.82%; the net profit excluding non-recurring gains and losses was 164 million yuan, a year-on-year increase of 66.04%. The basic earnings per share were 0.18 yuan

### Related Stocks

- [600073.CN](https://longbridge.com/en/quote/600073.CN.md)

## Related News & Research

- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)
- [Lyntris valued at $1.8 billion after shares fall in New York debut](https://longbridge.com/en/news/296376207.md)
- [FONDIA: Profitability improved sharply in H1 2026, driven by growth in Finland and the Baltics](https://longbridge.com/en/news/296439068.md)
- [GRAINS-Soybeans near three-week high on China demand, crop worries](https://longbridge.com/en/news/296295616.md)
- [China NMPA clears InnoCare Phase III trial of mesutoclax-azacitidine in treatment-naive AML](https://longbridge.com/en/news/296164458.md)